| Old Articles: <Older 981-990 Newer> |
|---|
 |
The Motley Fool
January 23, 2004
Jean Graham |
Keeping Abreast of Implants Inamed's race with Mentor for first rights to the silicone breast implant market hits a snag.   |
The Motley Fool
January 23, 2004
Alyce Lomax |
Amgen's Engine Is the drug company geared up for success? |
The Motley Fool
January 22, 2004
Alyce Lomax |
Worries for Wyeth Despite pain-free vaccine, the drug maker's results are still painful. |
The Motley Fool
January 20, 2004
David Nierengarten |
Adolor's Knocked-Out Drug The biotech's stock is pummeled after mixed-up trial results. |
BusinessWeek
January 26, 2004
Arlene Weintraub |
"I Can't Sleep" Insomnia and other sleep disorders are wreaking havoc on our health and taxing the economy. Drug companies see an opportunity. |
BusinessWeek
January 26, 2004
Arelene Weintraub |
"Exploring New Paradigms in Sleep" Two top execs from Sanofi, maker of the popular drug Ambien, talk about the challenges of staying on top in the insomnia market. |
InternetNews
January 14, 2004
Erin Joyce |
Drug Company Taps IBM, AMD for Computing Bristol-Myers decides to run all-important drug tests on cheaper lines of supercomputer clusters. Will competitors follow suit? |
The Motley Fool
January 13, 2004
David Nierengarten |
Vicuron's Booster Shot With a new "super-tough" antibiotic, Vicuron's stock is super high. |
BusinessWeek
January 19, 2004
John Carey |
Commentary: Ephedra: One Down, More To Go Laws should be changed to let the FDA remove dangerous supplements faster. |
Bio-IT World
January 12, 2004
Karen Hopkin |
High-Tech Search for the Fountain of Youth Dramatic advances may help biotechs develop drugs that slow aging. |
| <Older 981-990 Newer> Return to current articles. |
